Product Information

VALSARTAN 40 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1040 per EA under NDC 67877041530. Its NADAC has been published 385 times since Jul 10, 2019.

FDA first approved this application on Mar 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN 40 MG TABLET

Valsartan
$0.1040per EA

Strength

40 mg/1

NDC

67877041530

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VALSARTAN

Approval Type

Generic (ANDA)

FDA Application

ANDA205536

FDA Approved

3/12/2019

TE Code

AB

On Market Since

3/14/2019

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for VALSARTAN 40 MG TABLET has been published 385 times since Jul 10, 2019, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1040 per EA
All-time high$0.3963 (Aug 14, 2019)
All-time low$0.0960 (Jul 22, 2026)
52-week high$0.1141
52-week low$0.0960
Median price$0.1582
Average price$0.1805
Largest weekly change+62.2% (Apr 22, 2020)
Weeks tracked385
Tracking sinceJul 10, 2019

Price History

1W

+4.0%

1M

+8.0%

3M

+6.9%

6M

+5.0%

1Y

-5.0%

3Y

-21.4%

5Y

-59.6%

All

-73.8%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VALSARTAN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 40 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1040 per EA (NDC 67877041530), effective Nov 18, 2026.

How has the price of VALSARTAN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for VALSARTAN 40 MG TABLET has declined 73.8%. It has been tracked across 385 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for VALSARTAN 40 MG TABLET?

Since Jul 10, 2019, the NADAC for VALSARTAN 40 MG TABLET has ranged from a low of $0.0960 (Jul 22, 2026) to a high of $0.3963 (Aug 14, 2019), with a median of $0.1582 per EA.

Are there cheaper alternatives to VALSARTAN 40 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALSARTAN 40 MG TABLET, is $0.0991 per EA — about 5% below VALSARTAN 40 MG TABLET.

Who manufactures VALSARTAN 40 MG TABLET?

VALSARTAN 40 MG TABLET (NDC 67877041530) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.